Durvalumab Combined with Concurrent Chemoradiotherapy in Patients with Limited-Stage Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Clinical Trial
第一作者机构：[1]Hebei Med Univ, Hosp 4, Dept Radiotherapy, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714)：
Shen W. B.,Song C.,Wang H..Durvalumab Combined with Concurrent Chemoradiotherapy in Patients with Limited-Stage Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Clinical Trial[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2024,120(2):S60-S61.
APA：
Shen, W. B.,Song, C.&Wang, H..(2024).Durvalumab Combined with Concurrent Chemoradiotherapy in Patients with Limited-Stage Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Clinical Trial.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,120,(2)
MLA：
Shen, W. B.,et al."Durvalumab Combined with Concurrent Chemoradiotherapy in Patients with Limited-Stage Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Clinical Trial".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 120..2(2024):S60-S61
医学